Cosmetic Laser Dermatology
Mitch Goldman serves as Medical Director and Owner at Cosmetic Laser Dermatology in San Diego since September 2009, overseeing a center recognized for its significant advancements in cosmetic treatments. Currently, Mitch holds the position of Medical Director at Platinum Dermatology Partners and Chief Medical Officer at POMEGA INC. Furthermore, Mitch contributed as a Volunteer Clinical Professor of Dermatology at the University of California San Diego from June 1986 to 2021, focusing on procedural dermatologic surgery and resident training. Previous roles include Medical Director at SkinMedica Inc. and La Jolla Spa MD, as well as Aesthetic Medical Director at Lumenis LTD. Mitch co-founded Dermatology Associates of San Diego County, Inc. and completed a dermatology residency at UCLA following an internship at UC San Diego. Educational credentials include an MD from Stanford University and a BA in Biology from Boston University.
This person is not in any teams
Cosmetic Laser Dermatology
Cosmetic Laser Dermatology is a world-renowned dermatology center located in San Diego County, just a few minutes from beautiful La Jolla, Del Mar, and Downtown San Diego, where we combine the major cosmetic breakthroughs of science and medicine with the art of vision, creativity, and skill to bring our patients the ultimate in rejuvenation, and personalized attention, in a warm social environment of approachable luxury. When you visit Cosmetic Laser Dermatology, our board-certified dermatologists will work with you to design a treatment plan for rejuvenation based on your own unique cosmetic goals. We offer a variety of cosmetic dermatology procedures and are acclaimed experts in laser treatments, injectables, vein treatments, and liposculpture. The team of board-certified dermatologists is committed to providing each and every patient with the highest level of care in a comfortable setting. Cosmetic Laser Dermatology’s dermatologists are all highly respected in the field for their use of innovative treatments, involvement in advanced medical research, and continued participation in clinical trials.